Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD33-Targeted Therapies: Beating the Disease or Beaten to Death?
Maakaron JE, Rogosheske J, Long M, Bachanova V, Mims AS. Maakaron JE, et al. Among authors: rogosheske j. J Clin Pharmacol. 2021 Jan;61(1):7-17. doi: 10.1002/jcph.1730. Epub 2020 Sep 1. J Clin Pharmacol. 2021. PMID: 32875599 Review.
Adjusting Cyclophosphamide Dose in Obese Patients with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation.
Bachanova V, Rogosheske J, Shanley R, Burns LJ, Smith SM, Weisdorf DJ, Brunstein CG. Bachanova V, et al. Among authors: rogosheske j. Biol Blood Marrow Transplant. 2016 Mar;22(3):571-4. doi: 10.1016/j.bbmt.2015.10.012. Epub 2015 Oct 21. Biol Blood Marrow Transplant. 2016. PMID: 26497907 Free PMC article.
BEAM conditioning is well-tolerated and yields similar survival in obese and non-obese patients with lymphoma: no requirement for weight-based dose modifications.
Fair C, Shanley R, Rogosheske J, Lazaryan A, McClune B, Brunstein CG, Bachanova V. Fair C, et al. Among authors: rogosheske j. Bone Marrow Transplant. 2017 Mar;52(3):491-493. doi: 10.1038/bmt.2016.316. Epub 2017 Jan 9. Bone Marrow Transplant. 2017. PMID: 28067889 Free PMC article. Clinical Trial. No abstract available.
Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation.
Hegerova L, Bachan A, Cao Q, Vu HX, Rogosheske J, Reding MT, Brunstein CG, Arora M, Ustun C, Vercellotti GM, Bachanova V. Hegerova L, et al. Among authors: rogosheske j. Biol Blood Marrow Transplant. 2018 Dec;24(12):e20-e25. doi: 10.1016/j.bbmt.2018.07.028. Epub 2018 Jul 25. Biol Blood Marrow Transplant. 2018. PMID: 30053647 Free PMC article.
Prophylactic Foscarnet for Human Herpesvirus 6: Effect on Hematopoietic Engraftment after Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.
El Jurdi N, Rogosheske J, DeFor T, Bejanyan N, Arora M, Bachanova V, Betts B, He F, Holtan S, Janakiram M, Larson S, Maakaron J, Rashidi A, Warlick E, Wagner JE, Young JH, Weisdorf D, Brunstein CG. El Jurdi N, et al. Among authors: rogosheske j. Transplant Cell Ther. 2021 Jan;27(1):84.e1-84.e5. doi: 10.1016/j.bbmt.2020.10.008. Epub 2020 Oct 11. Transplant Cell Ther. 2021. PMID: 33053448 Free PMC article.
Effect of Keratinocyte Growth Factor on Hospital Readmission and Regimen-Related Toxicities after Autologous Hematopoietic Cell Transplantation for Lymphoma.
El Jurdi N, Fair C, Rogosheske J, Shanley R, Arora M, Bachanova V, Betts B, He F, Holtan S, Janakiram M, Maakaron J, Rashidi A, Warlick E, Weisdorf D, Brunstein CG. El Jurdi N, et al. Among authors: rogosheske j. Transplant Cell Ther. 2021 Feb;27(2):179.e1-179.e4. doi: 10.1016/j.jtct.2020.11.005. Epub 2020 Dec 13. Transplant Cell Ther. 2021. PMID: 33830033 Free article.
High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group.
El Jurdi N, Elhusseini H, Beckman J, DeFor TE, Okoev G, Rogosheske J, Lazaryan A, Weiler K, Bachanova V, Betts BC, Blazar BR, Brunstein CG, He F, Holtan SG, Janakiram M, Gangaraju R, Maakaron J, MacMillan ML, Rashidi A, Warlick ED, Bhatia S, Vercellotti G, Weisdorf DJ, Arora M. El Jurdi N, et al. Among authors: rogosheske j. Blood Cancer J. 2021 May 18;11(5):96. doi: 10.1038/s41408-021-00488-2. Blood Cancer J. 2021. PMID: 34006823 Free PMC article.
Higher Fludarabine and Cyclophosphamide Exposures Lead to Worse Outcomes in Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Adult Hematologic Malignancy.
Takahashi T, Scheibner A, Cao Q, Pearson R, Sanghavi K, Weisdorf DJ, Brunstein CG, Rogosheske J, Bachanova V, Warlick ED, Wiseman A, Jacobson PA. Takahashi T, et al. Among authors: rogosheske j. Transplant Cell Ther. 2021 Sep;27(9):773.e1-773.e8. doi: 10.1016/j.jtct.2021.05.013. Epub 2021 May 24. Transplant Cell Ther. 2021. PMID: 34044184 Free PMC article.
Effects of cyclophosphamide related genetic variants on clinical outcomes of adult hematopoietic cell transplant patients.
Takahashi T, Pearson R, Cao Q, Scheibner A, Sanghavi K, Weisdorf D, Brunstein C, Rogosheske J, Bachanova V, Warlick ED, Wiseman A, Jacobson PA. Takahashi T, et al. Among authors: rogosheske j. Cancer Chemother Pharmacol. 2022 Apr;89(4):543-549. doi: 10.1007/s00280-021-04389-w. Epub 2022 Jan 27. Cancer Chemother Pharmacol. 2022. PMID: 35083501
35 results